Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
Numakura K, Sekine Y, Osawa T, Naito S, Tokairin O, Muto Y, Sobu R, Kobayashi M, Sasagawa H, Yamamoto R, Nara T, Saito M, Narita S, Akashi H, Tsuchiya N, Shinohara N, Habuchi T. Numakura K, et al. Among authors: saito m. Int J Clin Oncol. 2024 Jul;29(7):1019-1026. doi: 10.1007/s10147-024-02538-8. Epub 2024 May 26. Int J Clin Oncol. 2024. PMID: 38797782
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.
Numakura K, Igarashi R, Takahashi M, Nara T, Kanda S, Saito M, Narita S, Inoue T, Niioka T, Miura M, Habuchi T. Numakura K, et al. Among authors: saito m. Cancer Biol Ther. 2024 Dec 31;25(1):2312602. doi: 10.1080/15384047.2024.2312602. Epub 2024 Feb 7. Cancer Biol Ther. 2024. PMID: 38327067 Free PMC article.
Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study.
Kodama H, Hatakeyama S, Matsuura T, Saito M, Nishida H, Hamaya T, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C. Kodama H, et al. Among authors: saito m. Int Urol Nephrol. 2024 Jul;56(7):2187-2193. doi: 10.1007/s11255-023-03934-1. Epub 2024 Feb 9. Int Urol Nephrol. 2024. PMID: 38332424
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy.
Narita S, Yanagisawa T, Hatakeyama S, Hata K, Fujita K, Ueda T, Tanaka T, Maita S, Chiba S, Sato H, Sekine Y, Kobayashi M, Kashima S, Yamamoto R, Numakura K, Saito M, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Iwabuchi I, Suzuki T, Ukimura O, Kimura T, Ohyama C, Nomura K, Habuchi T. Narita S, et al. Among authors: saito m. Prostate. 2025 Jan;85(1):73-81. doi: 10.1002/pros.24802. Epub 2024 Sep 30. Prostate. 2025. PMID: 39344365
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.
Takehara T, Nishida H, Ichikawa K, Nawano T, Takai S, Fukuhara H, Matsuura T, Maita S, Saito M, Murakami R, Hatakeyama S, Obara W, Saitoh H, Ohyama C, Habuchi T, Watanabe M, Tsuchiya N. Takehara T, et al. Among authors: saito m. Clin Exp Nephrol. 2024 Oct 25. doi: 10.1007/s10157-024-02578-4. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39453573
8,404 results